8-K: Profusa Inc. Transfers Listing to Nasdaq Capital Market

Profusa, Inc. announced its successful transfer to The Nasdaq Capital Market, effective May 15, 2026, meeting interim milestones set by the Nasdaq Hearings Panel.

Summary

• Profusa, Inc. has received confirmation from Nasdaq that it has complied with the deadline to file an application to transfer to The Nasdaq Capital Market.
• The transfer to The Nasdaq Capital Market is effective at the open of market on May 15, 2026.
• This move is a result of a Nasdaq Hearings Panel decision granting an exception to continue listing, subject to meeting interim milestones related to bid price and equity requirements.
• The company is continuing to evaluate the conditions set by the Panel and intends to take necessary actions to comply with all listing criteria within specified timeframes.
• There is no guarantee that the company will be able to maintain compliance or that its common stock will remain listed on The Nasdaq Capital Market.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral to slightly positive development, as the company has met an immediate listing requirement, but significant uncertainty remains regarding long-term compliance and continued listing.

Positives

• Successfully met the deadline to file an application for transfer to The Nasdaq Capital Market.
• Confirmed transfer to The Nasdaq Capital Market effective May 15, 2026.
• Received an exception from the Nasdaq Hearings Panel to continue listing, subject to meeting interim milestones.
• The company is actively working to meet the conditions set by the Nasdaq Hearings Panel.

Negatives

• The company must continue to meet specific interim milestones to ensure continued compliance with Nasdaq listing rules.
• There is no assurance that the company will be able to meet all conditions or maintain its listing on The Nasdaq Capital Market.

Risks

• The company's ability to maintain its listing on The Nasdaq Capital Market is subject to ongoing compliance with bid price and equity requirements.
• Failure to meet future interim milestones set by the Nasdaq Hearings Panel could result in delisting.
• There is uncertainty regarding the company's ability to obtain required stockholder approvals for certain actions.
• The company may not be able to execute its compliance plan within the specified timeframes.
• Potential for material differences between forward-looking statements and actual results due to various risks and uncertainties.

Future Outlook

The company intends to take the necessary actions to evidence compliance with all applicable listing criteria within the time periods specified by the Nasdaq Hearings Panel. However, there can be no assurance that the company will be able to do so, or that its common stock will remain listed on The Nasdaq Capital Market.

Management Comments

• The Company continues to evaluate the conditions set forth in the Decision Letter and intends to take the actions necessary to evidence compliance with all applicable listing criteria within the time periods specified by the Panel.
• There can be no assurance that the Company will be able to do so, or that the Company's common stock will remain listed on The Nasdaq Capital Market.

Industry Context

StockSavvy.ai notes that this filing indicates Profusa, Inc. is navigating the complexities of maintaining its listing on a major exchange, a common challenge for growth-stage companies in the competitive digital health sector. Successfully meeting these requirements is crucial for investor confidence and future capital access.

Stakeholder Impact

• Shareholders: The continued listing on Nasdaq, even on the Capital Market tier, is generally positive for maintaining liquidity and investor access, but the underlying compliance issues present ongoing risk.
• Creditors: Maintaining a Nasdaq listing can provide a degree of stability and confidence for creditors.
• Employees: The company's ability to maintain its listing can impact morale and the perceived stability of the organization.

Next Steps

• Continue to evaluate conditions set forth in the Nasdaq Hearings Panel Decision Letter.
• Take necessary actions to evidence compliance with all applicable Nasdaq listing criteria within specified time periods.
• Continue efforts to regain compliance with Nasdaq listing standards, including the Bid Price Rule and Equity Rule.

Key Dates

Recommendation

The company has successfully navigated an immediate listing hurdle by transferring to the Nasdaq Capital Market. However, significant risks remain regarding its ability to fully comply with Nasdaq's listing requirements in the future. Investors should hold their positions while monitoring the company's progress on compliance and its strategic initiatives.

Keywords

Profusa Inc., Nasdaq Capital Market, Listing Transfer, Bid Price Rule, Equity Rule, Compliance, Digital Health, Form 8-K